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RanavirusAmphibian species have experienced population declines and extinctions worldwide that are unprecedented
in recent history. Many of these recent declines have been linked to a pathogenic skin fungus, Batracho-
chytrium dendrobatidis, or to iridoviruses of the genus Ranavirus. One of the ﬁrst lines of defense against
pathogens that enter by way of the skin are antimicrobial peptides synthesized and stored in dermal granular
glands and secreted into the mucus following alarm or injury. Here, I review what is known about the
capacity of amphibian antimicrobial peptides from diverse amphibians to inhibit B. dendrobatidis or ranavirus
infections. When multiple species were compared for the effectiveness of their in vitro antimicrobial peptides
defenses against B. dendrobatidis, non-declining species of rainforest amphibians had more effective
antimicrobial peptides than species in the same habitat that had recently experienced population declines.
Further, there was a signiﬁcant correlation between the effectiveness of the antimicrobial peptides and
resistance of the species to experimental infection. These studies support the hypothesis that antimicrobial
peptides are an important component of innate defenses against B. dendrobatidis. Some amphibian
antimicrobial peptides inhibit ranavirus infections and infection of human T lymphocytes by the human
immunodeﬁciency virus (HIV). An effective antimicrobial peptide defense against skin pathogens appears to
depend on a diverse array of genes expressing antimicrobial peptides. The production of antimicrobial
peptides may be regulated by signals from the pathogens. However, this defense must also accommodate
potentially beneﬁcial microbes on the skin that compete or inhibit growth of the pathogens. How this
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This special issue is focused on the diverse array of antimicrobial
peptides that have been isolated from the skin of amphibians. Their
functions and potential applications for the treatment of human
disease will be described in detail in the contributions of other
authors. The focus of my research and the topic of my review is the
role of antimicrobial peptides in the protection of amphibians from
the pathogens that have been linked to global amphibian population
declines. Amphibians have a rich evolutionary history and have
evolved immune defenses to cope with a variety of microbes they
encounter. However, many species seem to be very susceptible to the
newly emerging disease, chytridiomycosis, caused by the skin fungus,
Batrachochytrium dendrobatidis. Here, I will review what is known
about the biology of this pathogen and the role that antimicrobial
peptides in the skin may play in defense against this pathogen. In
addition to a dominant fungal pathogen, many amphibians have
suffered population declines due to iridoviruses of the genus, Rana-
virus. I will also review our studies of the effectiveness of amphibian
antimicrobial peptides against viruses of lower vertebrates. Some
amphibian antimicrobial peptides were also shown to be effective
inhibitors of infection of human T lymphocytes by the human
immunodeﬁciency virus (HIV).
2. The problem of global amphibian declines
There are approximately 6400 described species of amphibians
[1], and new species continue to be discovered [2,3]. Efforts to assess
the status of amphibian species in the last several decades have
demonstrated that many amphibian populations have declined, and
a number of species appear to have recently become extinct [4–8].
It is generally thought that a number of interacting factors may con-
tribute to amphibian declines. Among them are habitat destruction
[7–10], climate change [11–15], increased UV-B [16–20], introduction
of non-native species [21–26], and environmental chemicals [27–29].
Importantly, growing evidence links global amphibian declines to
an emerging infectious disease, chytridiomycosis, caused by the
chytrid fungus, B. dendrobatidis [15,30–34, reviewed in 35–37] and
to iridoviruses of the genus Ranavirus [38–45 and reviewed in 35–
37,46,47].
3. The biology of B. dendrobatidis
B. dendrobatidis is classiﬁed as a chytrid fungus primarily due to
the ultrastructural features of its motile zoospore [30,31]. Possession
of a ﬂagellated zoospore places this fungus at the base of the fungal
evolutionary tree, and genetic comparisons demonstrate that it is
distinct from other chytrid fungi [48,49]. Thus, B. dendrobatidis shares
few characteristics with other chytrids or more evolved fungal species
that are of medical importance such as Histoplasma capsulatum,
Candida albicans, or Cryptococcus neoformans [49]. B. dendrobatidis is
the only known chytrid fungus that is a parasite of vertebrates [48,50].
Infection of its amphibian host occurs when a swimming zoospore
lands on the skin of adults or the mouthparts of tadpoles and encysts
(stops movement and settles), resorbs the ﬂagellum, and forms a
cell wall. Through mechanisms that are not fully understood, the
pathogen moves from the surface of the skin to the rapidly dividing
basal layer of the stratum corneum. There, it enters healthy cells, and
the organism, now called a thallus (or germling), grows in size and
develops thread-like rhizoids. This pattern of chytrid development
within cells is termed “exogenous development” [51]. Exogenous and
endogenous development refer to the location of the nucleus. In
endogenous development, the nucleus remains in the zoospore cyst
during development to the zoosporangium stage. In exogenous
development the nucleus leaves the zoospore cyst through a germ
tube, and the zoosporangium develops from a swelling in the germtube. Other terminology might make this relationship to the inside
and outside of the frog more clear. “Epibiotic” (developing on the
surface of the substrate) and “endobiotic” (developing inside of the
substrate) are terms historically used to describe the relationship of
the chytrid to its substrate [51]. It seems clear from this description
that B. dendrobatidis is capable of both epibiotic growth and endo-
biotic growth. The maturing thallus becomes a single urn-shaped
zoosporangium in which the zoospores develop. As this process of
growth and maturation occurs, the skin cells are moving toward the
surface and becoming keratinized. At about the time the skin cells
have reached the surface, the zoosporangium is mature. The discharge
papilla opens, and mature zoospores swim out [30,31,52]. There
appears to be little or no lateral transmission of fungal cells within the
epidermis, but some zoospores may be discharged into intercellular
spaces [52]. Zoospores are motile for only about 24 h before they
encyst or die. The life cycle in culture at 22 °C takes about 4 to 5 days,
and it is assumed that it is the same within the skin [30,52]. On the
skin of infected frogs, thalli are found in clusters suggesting zoospore
transmission over a short distance from one area of the skin to
another. Thus, it is likely that antimicrobial peptides in the mucus
would be a signiﬁcant deterrent to initial colonization of the skin as
well as further spread on the host. In calm water, zoospores move
less than 2 cm [53]. B. dendrobatidis does not possess a stage that
can resist desiccation or temperatures above 30 °C [53,54]. In the
presence of organic material, the fungus can persist at least 7 weeks
and remain infectious in lake water [55,56]. This persistence in
lake water suggests that it can obtain sufﬁcient nutrients from
the water and move through a number of repeats of its life cycle
without the need for an amphibian host. In a recent study of B.
dendrobatidis prevalence in water samples in Spain, it was detected in
64% of ponds, and the organism persisted for at least 12 weeks in
experimental mesocosms [57]. Because the fungus can colonize the
mouthparts of tadpoles, they may serve as carriers to maintain the
pathogen in the environment when adults are dispersed [32,58,59].
Thus, B. dendrobatidis is likely to persist in the environment for long
periods between disease outbreaks. Since it can persist in the
environment, long-term protection of a species will likely depend
on good innate or adaptive immune defenses. The mechanism by
which the fungus kills its amphibian host is not fully understood. Two
hypotheses have been suggested [31,32]. The chytrid may produce a
toxic substance, or the presence of the infection disturbs the ﬂuid and
electrolyte balance. Recent studies suggest that disruption of skin
function due to infection impairs the retention of sodium, potassium,
and chloride ions, and this electrolyte imbalance may be the cause of
death [60].
4. Ranaviruses and amphibian declines
Iridoviruses are a family of DNA viruses that infect invertebrates,
ﬁsh, amphibians, and reptiles [reviewed in 35–37,46,47]. Iridoviruses
in the genus Ranavirus have been associatedwith amphibianmortality
events in the western United States (Arizona, Colorado, Minnesota,
North Dakota, and Utah) [40,45,61], the eastern United States
(Massachusetts, New Hampshire, North Carolina, and Tennessee)
[61], in Venezuela [41], in Saskatchewan andManitoba Canada [42], in
Australia [44], and in the United Kingdom [39].
5. Antimicrobial peptide defenses against B. dendrobatidis
5.1. Puriﬁed peptides
At the time of writing of this review, my laboratory has tested the
activity of 41 puriﬁed antimicrobial peptides from 27 species for their
ability to inhibit growth of B. dendrobatidis in culture [62–69 and
reviewed in 70,71]. Of these peptides, 83% were inhibitory with a
minimal inhibitory concentration (MIC) of 100 μM or less. Many had
Table 1
Minimal inhibitory concentration (MIC) of peptides from various amphibian species of the families Hylidae, Pipidae and Ranidae against zoospores of B. dendrobatidis.
Family Species of origin Peptide Sequence MIC (μM) Reference
HYLIDAE Hylomantis lemur Dermaseptin-L1 GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS N100 [68]
Hylomantis lemur Phylloseptin-L1 LLGMIPLAISAISALSKL 100 [68]
PIPIDAE Xenopus laevis CPF GFASFLGKALKAALKIGANLLGGTPQQ-OH 12.5 a
X. laevis Magainin II GIGKFLHSAKKFGKAFVGEIMNS 162 a
X. laevis PGLa GMASKAGAIAGKIAKVALKAL.NH2 50 a
RANIDAE Rana boylii Brevinin-1BYa FLPILASLAAKFGPKLFCLVTKKC 12.5 [67]
R. boylii Brevinin-1BYc FLPILASLAAKLGPKLFCLVTKKC 6.25 [67]
R. boylii Ranatuerin-2BYa GILSTFKGLAKGVAKDLAGNLL DKFKCKITGC 25 [67]
R. boylii Ranatuerin-2BYb GIMDSVKGLAKNLAGKLLDSLKCKITGC 12.5 [67]
R. luteiventris Ranatuerin-2La GILDSFKGVAKGVAKDLAGKLLDKLKCKITGC 50 [62]
R. muscosa Ranatuerin-2Ma GLLSSFKGVAKGVAKNLAGKLLEKLKCKITGC 50 [66]
R. muscosa Ranatuerin-2Mb GIMDSVKGVAKNLAAKLLEKLKCKITGC 25 [66]
R. muscosa Temporin-1M FLPIVGKLLSGLL.NH2 100 [66]
a L. Rollins-Smith and J. Ramsey, unpublished.
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Some of the most effective peptides had MIC values of about 6–12 μM
(brevinin-1BYa, brevinin-1BYc, brevinin-1TRa, brevinin-2Ob, esculen-
tin-1A, esculentin-2L, ranatuerin-1, ranatuerin-2BYb, palustrin-3A,
ranalexin, and CPF).
5.2. Natural mixtures of skin peptides
Although testing puriﬁed peptides for growth inhibition of a
speciﬁc pathogenprovides very important information about the likely
potency of the skin secretions of a given species, we are limited in the
number of peptides that can be isolated, characterized, and tested.
Furthermore, the peptides are not secreted as single sets of molecules
but rather as complex mixtures of defensive peptides and other
defensivemolecules [reviewed in 72–79]. Therefore,my laboratory has
also tested natural mixtures of peptides from the skin secretions of 24
additional species to determine their effectiveness in inhibiting growth
of B. dendrobatidis [64,66–68,80–82]. When there were sufﬁcient
peptides to determine an MIC value for the mixture of peptides, we
determined a measure of effectiveness based on the MIC and the
amount of total peptides secreted per gramofweight or per cm2 of skin
surface. We termed this MIC-equivalents [66,81]. For other species
(generally very small tropical species), insufﬁcient peptides were
collected from individuals to determine an MIC value. Therefore, we
computed the percent inhibition at aﬁxed concentration of 50 μg/ml of
peptides multiplied by the amount of peptides produced per gram
body weight [80]. The relative effectiveness of the peptide mixtures
generally correlates with the survival of species in the wild [66] and
their resistance to experimental infection [81]. Based on relative
peptide effectiveness, we have predicted the survival or susceptibility
of nine species of amphibians in a species assemblage in Panama [80].
6. Antimicrobial peptide defenses against viruses of lower
vertebrates
Because of the amphipathic structure of most amphibian anti-
microbial peptides, we hypothesized that many of themwould inhibit
the infection of target cells by viruses with lipid-containing envelopes.
The ranavirus, frog virus 3 (FV3), does not possess a conventional viral
envelope, but it does have a lipid membrane located between the
outer capsid and the inner DNA core [46]. Five of six antimicrobial
peptides tested effectively inhibited infection of target cells by FV3 in a
plaque reduction assay (esculentin-2P, ranatuerin-2P, dermaseptin-1,
temporin A, magainin II, and PGLa). The peptides were even more
effective against an enveloped herpesvirus that infects ﬁsh, the
channel catﬁsh virus. The peptides acted rapidly over a wide range of
temperatures [83,84]. After demonstrating the effectiveness of the
amphibian antimicrobial peptides to inhibit viruses that afﬂict lower
vertebrates, we collaborated with others to test the effectiveness of apanel of amphibian antimicrobial peptides as inhibitors of the human
immunodeﬁciency virus (HIV) infection of T lymphocytes. Three
peptides (caerin 1.9, caerin 1.1, and maculatin 1.1) from Australian
species were very effective inhibitors of HIV infection at low
concentrations (10–20 μM). They inhibited virus infectivity at a
point prior to membrane fusion and reverse transcription. While
inhibiting virus infection, they showed very limited toxicity to the
target T cells. Furthermore, they inhibited the uptake and transfer of
virus particles by dendritic cells evenwhen the peptides were applied
up to 8 h after virus exposure to dendritic cells [85]. Thus, we feel that
these peptides, or related peptides, are good candidates for further
study towards the development of an effective vaginal microbicide.
7. What is known about the interactions of amphibian
antimicrobial peptides with membranes of B. dendrobatidis
and viral envelopes?
It is generally thought that amphibian antimicrobial peptides
inhibit B. dendrobatidis infection by disruption of the membrane of
the infectious zoospore. Evidence for this is that the zoospore which
lacks a cell wall is more sensitive in vitro to a number of amphibian
antimicrobial peptides than the more mature zoosporangium which
possesses a cell wall [63,64]. Both maturing zoosporangia and
zoospores are effectively destroyed within about 4 days. By micro-
scopic examination, intact cells at several stages of maturation were
dramatically reduced. This was interpreted as evidence that the
peptides are fungicidal against both zoospores andmaturing sporangia.
Thus, we believe the peptides can penetrate through cell walls to kill
the sporangia [63]. Two puriﬁed peptides from Rana pipiens (Lithobates
pipiens) [86] inhibit growth of B. dendrobatidis effectively at both 22 °C
and10 °C.When the growth inhibition curves at differing temperatures
were compared for the two puriﬁed peptides, both peptidesweremore
effective at the lower temperature. We interpreted this increased
effectiveness as evidence that peptides can bind and disrupt cell
membranes at 10 °C as effectively as they do at 22 °C [63]. Further, at the
higher temperature, the fungus may grow more rapidly and produce
more proteases that interfere with peptide function [87]. It is also the
case that at lower temperatures, more zoospores are produced at each
round of replication. Thus, at lower temperatures, more fungal cells at
the most peptide-sensitive life stage are produced [88].
Inhibition of infection by ranaviruses and HIV is also thought to be
due to the action of the antimicrobial peptides on the membrane-like
envelope of the viruses. The greater sensitivity of channel catﬁsh virus
which contains an envelope in comparison with FV3 which lacks a
conventional viral envelope, suggests that the lipid-containing
envelope is the most sensitive component of the viruses [83,84].
Likewise, amphibian antimicrobial peptides inhibited infection with
the enveloped HIV andmurine leukemia virus but not by reovirus that
lacks an envelope [85]. Preincubation of HIV with amphibian
1596 L.A. Rollins-Smith / Biochimica et Biophysica Acta 1788 (2009) 1593–1599antimicrobial peptides prevented viral fusion to target cells and
disrupted the envelope [85].
8. What regulates antimicrobial peptide production in
amphibians?
Little is known about the regulation of antimicrobial peptide
synthesis in amphibian skin. It is thought that microbes or microbial
products at the skin surface would be detected by epithelial cell recep-
tors such as toll-like receptors or other pattern recognition receptors
and somehow signal to the granular glands for increased synthesis of
antimicrobial peptides. Alternatively, granular gland cells may possess
pathogen recognition receptors. It has been reported that exposure to
pathogenic bacteria or yeast resulted in increased synthesis of anti-
microbial peptides in Rana esculenta and Bombina orientalis [89,90].
After gland depletion induced by electrostimulation, frogs maintained
in a sterile environment failed to restore antimicrobial peptides
whereas those exposed to microorganisms did [89,90]. Although a
number of the genes that encode antimicrobial peptides have nowbeen
described, few investigators have examined the potential regulatory
regions of the genes. A single gene in B. orientalis codes for the peptides
BLP-3 andGH-1[90]. A separate gene in this species codes forBLP-7 [91].
The promoter region of both genes contains a potential NFκB binding
site and NF-IL6 binding site [90]. A similar analysis of the promoter
region of gaegurin 4 from Rana rugosa revealed the presence of a
putative NF-IL6 binding site, two putative GATA-1 binding sites, and a
binding site for the dorsal (dl) transcription factor [92]. Deletions of the
dl site resulted in decreased transcription in a reporter assay system
[92]. Thus, it seems clear that for several amphibian antimicrobial
peptides, transcription resulting from exposure to microbial products
may be activated by signals mediated by rel family transcription factors
or other immune-related transcription factors.
9. What other factors might impact antimicrobial peptides
production and release?
Corticosteroid hormones are powerful regulatory hormones that
mobilize carbohydrate reserves in amphibians as well as other
vertebrates [93–95]. Elevated corticosteroids are associated with
stress in amphibians as well as other vertebrate species [96]. If stress
elevates corticosteroids and they suppress the synthesis of antimi-
crobial peptides, then stressed animals may be more susceptible to
opportunistic pathogens. Previous studies in R. esculenta have shown
that application of pharmacological concentrations of corticosteroid
hormones inhibits new synthesis of antimicrobial peptides and
transcription of mRNA for the esculentin peptide precursor following
discharge of peptides [97]. Using Xenopus laevis, we have also
investigated the effects of pharmacological concentrations of corti-
costerone on re-synthesis of skin peptides following maximal
depletion. We observed that synthesis of all hydrophobic skin
peptides released by granular glands was profoundly inhibited [L.
Rollins-Smith, unpublished data]. Future studies will investigate the
effects of more physiologically relevant concentrations of corticoster-
oids. In addition to corticosteroids, we investigated whether pesti-
cides in aquatic systems would inhibit antimicrobial peptide
synthesis. A study of the effects of carbaryl on juvenile foothill
yellow-legged frogs (Rana boylii) collected in California showed that a
sublethal exposure to this common pesticide inhibited the production
or release of antimicrobial peptides in this species [68].
10. What is known about the diversity of antimicrobial peptides
within amphibian species? What process is responsible for the
generation of this diversity?
For most amphibian species that have been studied, only a few
representative individuals were sampled to provide the peptides thatwere isolated and characterized. Therefore it remains an open
question just how variable are the antimicrobial peptide repertoires
of individual species. The skin peptide proﬁles of thirty individuals
from one natural population of Rana muscosa and forty individuals
from a second geographically separated population of R. muscosawere
compared by matrix-assisted laser desorption ionization (MALDI)
time-of-ﬂight (TOF) mass spectrometry. The expression proﬁle of the
three previously described antimicrobial peptides for this species
(ranatuerin-2Ma, ranatuerin-2Mb, and temporin-1M) did not differ
among the individuals in the two populations [98]. This would suggest
that there is very limited variation in the expressed antimicrobial
peptides between populations of the same species. However, a study
of the variation in the genes encoding brevinin-1 peptides in the
geographically widespread northern leopard frog, Rana pipiens
(Lithobates pipiens) [86], shows that there are at least ﬁve brevinin-
1 loci in R. pipiens and at least three in the closely related species Rana
chiricahuensis. This newly described locus has been named Brevinin1.1,
and it encodes at least thirteen brevinin-1 peptides in R. pipiens and
three in R. chiricahuensis [99,100; J. Tennessen et al., unpublished].
MALDI-TOF analysis of the suite of expressed brevinin-1 peptides in
three geographically distinct populations of R. pipiens revealed
distinct patterns of expression. Each population expressed three or
four brevinin-1 peptides, and the relative amounts differed signiﬁ-
cantly by population [J. Tennessen et al., unpublished]. This suggests
that there has been a process of selection for expression of peptides
effective against a set of pathogens found in each geographic region. A
study of the expressed mRNAs for temporin peptides from twelve
individuals of the Japanese mountain brown frog Rana ornativentris
showed a surprisingly high degree of genetic variation [101]. In the
Australian species, Litoria caerulea, six unique peptides of the caerin 1
family have been isolated and characterized as expressed peptides
[102–104], and ﬁve additional peptide sequences were discovered by
analysis of the cDNAs prepared from the expressed poly-A mRNA
fraction from another individual [105]. Thus, this species has at least
eleven nearly identical peptides of the caerin 1 family. The most likely
mechanism to explain this peptide diversity is gene duplication
followed by positive selection for retention of successful variants that
allow the host to defend itself against a speciﬁc pathogen [99,105,106].
11. What is the relationship of antimicrobial peptides in skin
secretions to beneﬁcial skin bacteria?
The skin of amphibians is inhabited by a rich array of skin microbes
[98,107–110]. While some of them are potential pathogens, most are
probably benign and may be beneﬁcial. Using classical morphological
and phenotypic identiﬁcation methods, a number of previous studies
have identiﬁed bacteria associated with amphibian disease outbreaks,
and electron micrographs of B. dendrobatidis-infected skin show
occasional bacteria within empty zoosporangia that have discharged
their zoospores [52]. Bacteria that frequently are identiﬁed in studies
of diseased amphibians include Aeromonas hydrophila, Citrobacter
freundii, Escherichia coli, Flavobacterium indologenes, Morganella
morganii, Pseudomonas ﬂuorescens, and Vibrio mitchnikovii [111–114].
Although some of these organisms are also found on healthy skin,
these studies are not very informative with respect to skin bacteria
that may be potentially beneﬁcial. More recent studies have
investigated the skin microbes associated with several amphibian
species that can inhibit growth of B. dendrobatidis and other patho-
genic fungi in vitro.
To examine the hypothesis that cutaneous bacteria may protect
host salamanders from lethal infection by B. dendrobatidis and other
pathogenic fungi, Harris et al. [108–110] isolated numerous bacterial
colonies from two species (Plethodon cinereus and Hemidactylium
scutatum) and tested them for their ability to inhibit growth of B.
dendrobatidis and the ascomycete fungus, Mariannaea sp., pathogenic
to salamander eggs. Members of eight genera of bacteria strongly
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lenge assays. The inhibitory bacteria belonged to the following genera:
Arthrobacter, Bacillus, Kitasatospora, Lysobacter, Paenibicillus, Pedobac-
ter, Pseudomonas, and Streptomyces [108]. In a second study of the
salamander H. scutatum, antifungal bacteria from 16 genera (48
species) were identiﬁed [110]. The Harris lab has also recently visual-
ized dividing bacteria on the skin of amphibians indicating that the
skin environment is appropriate for reproduction as well as survival
[109]. Bacteria isolated from the salamander P. cinereus were shown
to produce the antifungal metabolites 2,4-diacetylphloroglucinol
(2,4-DAPG), indole-3-carboxaldehyde and violacein [115,116]. Our
own studies done in collaboration with Cheryl Briggs, Vance
Vredenburg, and Reid Harris show that the mountain yellow-legged
frog, R. muscosa, also possesses a number of skin bacteria that can
inhibit growth of B. dendrobatidis [98]. R. muscosa populations are
declining currently in a pattern that suggests B. dendrobatidis is the
leading cause of declines [34]. Our studies suggest that populations of
R. muscosa that are persisting in the presence of B. dendrobatidis are
more likely to have a high-proportion of individuals with B.
dendrobatidis-inhibiting bacteria than those that are declining [98].
In contrast to the very limited information about amphibian skin
microbes, there is abundant evidence of the association of bacteria
with mucosal surfaces of mammalian airways, digestive tract, and
urogenital tracts. Often, the bacteria can be shown to develop bioﬁlms
in which multiple bacteria cooperate to create a matrix of living cells
and bacterial products [117–119]. We therefore think it is reasonable
to assume that communities of beneﬁcial bacteria exist in association
with the mucus layer and epidermis of amphibian skin. The presence
of this beneﬁcial microbial community could enhance the production
of antimicrobial peptides that would make the amphibian host less
susceptible to infection by B. dendrobatidis. It has been suggested that
these potentially beneﬁcial bacteria could be harvested from hosts
that are resistant to B. dendrobatidis and transferred to susceptible
species to provide protection [108].
The observation that skin microbes may play a role in defense
against fungal pathogens raises many questions about the interactions
of the skin microbes with the skin epithelium and possible effects on
production of antimicrobial peptides. Are the resident bacteria unique
to each species or shared among species? Are resident bacteria
resistant to host antimicrobial peptides? Are the microbes necessary
for the continued production of antimicrobial peptides? Does the
microbial community affect the expressed antimicrobial peptide
repertoire? These and other questions will need to be addressed
before the application of beneﬁcial bacteria as a “bio-augmentation”
strategy can be considered for use to protect wild amphibians.
12. Concluding remarks and future directions for research
Antimicrobial peptides are secreted into the skin mucus following
discharge of the contents of dermal granular glands. They serve as a
ﬁrst line of defense against potential pathogens that may be present at
the skin surface. The mucus is also home to a community of bacteria
that may play a role in protection from invasive pathogens. Therefore,
control by antimicrobial peptides may need to be balanced with the
need to accommodate the skin community. It is tempting to speculate
that the skin epithelium and granular glandsmay be able to detect and
discriminate between potentially dangerous skin pathogens and
benign skin microbes and may regulate synthesis and release of
antimicrobial peptides to kill harmful bacteria. The repertoire of
antimicrobial peptides may be selected to contain peptides that target
speciﬁc pathogens but do not harm symbiotic microbes. The complex
interactions of skin microbes with the antimicrobial peptides is an
important area of research in view of the intense interest among
amphibian conservation biologists to use a bio-augmentation
approach to try to protect highly endangered species around the
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